Healthcare/Hospital Law
Apr. 10, 2007
Vioxx Strategy Unfolds Slowly, and It Seems to Merck's Advantage
LOS ANGELES - Merck heads into its fourth California Vioxx liability trial this week with a remarkable record.
Daily Journal Staff Writer
LOS ANGELES - Merck heads into its fourth California Vioxx liability trial this week with a remarkable record.
The painkiller's New Jersey-based manufacturer has won four of five federal trials and six of 10 state trials involving claims the drug caused health problems and the company failed to warn physicians and patients about the risks.
&...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In